Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.
Data(s) |
2012
|
---|---|
Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/22624058 PONE-D-12-07950 PLoS One, 2012, 7 (5), pp. e37648 - ? http://hdl.handle.net/10161/10587 1932-6203 |
Relação |
PLoS One 10.1371/journal.pone.0037648 |
Tipo |
Journal Article |
Cobertura |
United States |
Resumo |
BACKGROUND: Generation of potent anti-HIV antibody responses in mucosal compartments is a potential requirement of a transmission-blocking HIV vaccine. HIV-specific, functional antibody responses are present in breast milk, and these mucosal antibody responses may play a role in protection of the majority of HIV-exposed, breastfeeding infants. Therefore, characterization of HIV-specific antibodies produced by B cells in milk could guide the development of vaccines that elicit protective mucosal antibody responses. METHODS: We isolated B cells from colostrum of an HIV-infected lactating woman with a detectable neutralization response in milk and recombinantly produced and characterized the resulting HIV-1 Envelope (Env)-specific monoclonal antibodies (mAbs). RESULTS: The identified HIV-1 Env-specific colostrum mAbs, CH07 and CH08, represent two of the first mucosally-derived anti-HIV antibodies yet to be reported. Colostrum mAb CH07 is a highly-autoreactive, weakly-neutralizing gp140-specific mAb that binds to linear epitopes in the gp120 C5 region and gp41 fusion domain. In contrast, colostrum mAb CH08 is a nonpolyreactive CD4-inducible (CD4i) gp120-specific mAb with moderate breadth of neutralization. CONCLUSIONS: These novel HIV-neutralizing mAbs isolated from a mucosal compartment provide insight into the ability of mucosal B cell populations to produce functional anti-HIV antibodies that may contribute to protection against virus acquisition at mucosal surfaces. |
Formato |
e37648 - ? |
Idioma(s) |
ENG |
Palavras-Chave | #Antibodies, Monoclonal #Antibodies, Neutralizing #B-Lymphocytes #Colostrum #Epitopes, B-Lymphocyte #Female #Fluorescent Antibody Technique, Indirect #HIV Antibodies #HIV Envelope Protein gp120 #Humans #Neutralization Tests #Pregnancy |